Rpo »

Recursion Pharmaceuticals shares owned by Rpo

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Rpo from 13F filings

Historical chart of Rpo investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Rpo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Rpo

Quarter filed Position value Share count Share price at filing
2025-12-31 $62k 15k 4.09

More positions owned by Rpo

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Bank of America Corporation Call Option (BAC)
ConocoPhillips (COP)
Spdr Series Trust State Street Spd Call Option (XME)
Morgan Stanley Com New Call Option (MS)
Apple (AAPL)
Qualcomm Call Option (QCOM)
Strategy Note 0.625% 9/1 (Principal)
Strategy Note 12/0 (Principal)
Liberty All Star Equity Sh Ben Int (USA)
Bitwise Solana Staking Etf Com Shs Of Benef (BSOL)
Boulder Growth & Income Fund (STEW)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)

View all positions for Rpo

Top funds holding Recursion Pharmaceuticals

Vanguard Group
BlackRock
ARK Investment Management
State Street Corporation
Baillie Gifford & Co
Softbank Group Corp
Kinnevik AB
Geode Capital Management
MIC Capital Management UK
Susquehanna International
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Data Collective IV GP
Norges Bank Investment Management
Exor Investments

View all funds holding Recursion Pharmaceuticals